Financial Data and Key Metrics Changes - Q4 2022 revenues amounted to $5,500,000, representing a 29% increase year-over-year [13] - Total revenues for the twelve months ending 12/31/2022 reached $16,700,000, an increase of 28.7% year-over-year [13] - Gross margins improved to 75% for 2022 compared to 62% for 2021, with Q4 gross margins reaching 78% [13] - Operating expenses for 2022 decreased by 4% year-over-year, while Q4 operating expenses increased by 9% [14] Business Line Data and Key Metrics Changes - The company achieved record levels in units shipped and treatments, driven by the adoption of Ultramist [6] - Operating expenses decreased year-over-year due to automation and reduced headcount [6] Market Data and Key Metrics Changes - The chronic wound care market is valued at $45 billion, with SANUWAVE positioned favorably due to strong clinical evidence and reimbursement support [5] - The biological skin substitute market is experiencing turmoil, with reimbursement cuts expected to reach 80-90% by next year [18] Company Strategy and Development Direction - The company aims for sustainable, profitable growth in 2023, focusing on leveraging existing infrastructure [8] - Plans to enhance investor relations and marketing strategies to increase awareness and adoption of products [17] - Participation in industry trade shows to promote products and educate potential customers [19] Management's Comments on Operating Environment and Future Outlook - Management acknowledged challenges in the supply chain but expressed optimism about achieving record revenue growth and profitability in 2023 [21] - Anticipated first-quarter revenue growth of 14-20% year-over-year, with expectations for acceleration in Q2 [22] Other Important Information - The company successfully relisted on the OTCQB on January 30, 2023, after addressing accounting issues [8] - Key additions to the management team were made to drive profitable growth [10] Q&A Session Summary Question: What might peak production look like in the next couple of quarters? - The company is currently at a pace of 40 new products per month, scheduled to ramp to 100 by the end of the year [29] - The applicator side is running 20% ahead of demand, with plans to increase production by 70-80% by year-end [31]